TCM
FLGT icon

Teza Capital Management’s Fulgent Genetics FLGT Stock Holding History

Teza Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,504
Closed -$207K – 595
2024
Q3 		$207K Sell
9,504
-1,763
-16% -$39.4K 0.02% 548
2024
Q2 		$221K Buy
+11,267
New +$235K 0.03% 516
2024
Q1 		– Sell
-8,118
Closed -$235K – 620
2023
Q4 		$235K Buy
+8,118
New +$217K 0.04% 464

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Teza Capital Management's FLGT Position: Q4 2024 in Review

Teza Capital Management sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 9,504 shares — an estimated $207K sold.

Teza Capital Management first reported a position in FLGT in Q4 2023 and held it in 3 quarters. The position peaked at $235K in Q4 2023. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Teza Capital Management reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Teza Capital Management sold 9,504 Fulgent Genetics shares in Q4 2024, an estimated $207K.
  • Teza Capital Management first reported a position in Fulgent Genetics in Q4 2023 and held it in 3 quarters.
  • Teza Capital Management's Fulgent Genetics position peaked at $235K in Q4 2023.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Teza Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.